CFM
TEVA icon

Capricorn Fund Managers’s Teva Pharmaceuticals TEVA Stock Holding History

Capricorn Fund Managers’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-284,059
Closed -$2.29M – 105
2022
Q3 		$2.29M Buy
284,059
+221,286
+353% +$1.96M 0.72% 49
2022
Q2 		$472K Buy
+62,773
New +$547K 0.09% 91

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Capricorn Fund Managers's TEVA Position: Q4 2022 in Review

Capricorn Fund Managers sold out of Teva Pharmaceuticals (TEVA) in Q4 2022, closing a stake of 284,059 shares — an estimated $2.29M sold.

Capricorn Fund Managers first reported a position in TEVA in Q2 2022 and held it in 2 quarters. The position peaked at $2.29M in Q3 2022. 422 funds tracked by Wall St. Rank hold TEVA as of Q4 2022.

  • Capricorn Fund Managers reported no remaining Teva Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Capricorn Fund Managers sold 284,059 Teva Pharmaceuticals shares in Q4 2022, an estimated $2.29M.
  • Capricorn Fund Managers first reported a position in Teva Pharmaceuticals in Q2 2022 and held it in 2 quarters.
  • Capricorn Fund Managers's Teva Pharmaceuticals position peaked at $2.29M in Q3 2022.
  • 422 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2022.

Based on Capricorn Fund Managers's 13F filing for Q4 2022, filed 17 Jan 2023.